Can a smart monitor catch dangerous low blood sugar in new moms?
NCT ID NCT06141941
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using a continuous glucose monitor (CGM) in the hospital right after childbirth could better detect low blood sugar (hypoglycemia) in women with type 1 or type 2 diabetes, compared to standard finger-stick tests. Thirty-nine women in their third trimester who owned a smart device participated. The goal was to see if CGM could reduce the number of hypoglycemic episodes during their postpartum hospital stay.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- continuous glucose monitoring (CGM) device
- What this could lead to
- If it works, this could help doctors better detect and prevent low blood sugar in new mothers with diabetes during their hospital stay.
- What could go wrong
- This is a small, completed study with only 39 participants, so results may not apply to all women. The device is for monitoring only and does not treat the underlying diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.